These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36464111)

  • 1. A comparative study on micelles, liposomes and solid lipid nanoparticles for paclitaxel delivery.
    Dattani S; Li X; Lampa C; Lechuga-Ballesteros D; Barriscale A; Damadzadeh B; Jasti BR
    Int J Pharm; 2023 Jan; 631():122464. PubMed ID: 36464111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation.
    Rosière R; Van Woensel M; Gelbcke M; Mathieu V; Hecq J; Mathivet T; Vermeersch M; Van Antwerpen P; Amighi K; Wauthoz N
    Mol Pharm; 2018 Mar; 15(3):899-910. PubMed ID: 29341619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
    Wang F; Li L; Liu B; Chen Z; Li C
    Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment.
    Khallaf RA; Salem HF; Abdelbary A
    Drug Deliv; 2016 Nov; 23(9):3452-3460. PubMed ID: 27240935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro and In Vivo Efficacy of Self-Assembling RGD Peptide Amphiphiles for Targeted Delivery of Paclitaxel.
    Saraf P; Li X; Wrischnik L; Jasti B
    Pharm Res; 2015 Sep; 32(9):3087-101. PubMed ID: 26063045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy.
    Banerjee I; De K; Mukherjee D; Dey G; Chattopadhyay S; Mukherjee M; Mandal M; Bandyopadhyay AK; Gupta A; Ganguly S; Misra M
    Acta Biomater; 2016 Jul; 38():69-81. PubMed ID: 27109765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical delivery of paclitaxel for treatment of skin cancer.
    Bharadwaj R; Das PJ; Pal P; Mazumder B
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1482-94. PubMed ID: 26850463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.
    Chirio D; Gallarate M; Peira E; Battaglia L; Muntoni E; Riganti C; Biasibetti E; Capucchio MT; Valazza A; Panciani P; Lanotte M; Annovazzi L; Caldera V; Mellai M; Filice G; Corona S; Schiffer D
    Eur J Pharm Biopharm; 2014 Nov; 88(3):746-58. PubMed ID: 25445304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined delivery of paclitaxel and tanespimycin via micellar nanocarriers: pharmacokinetics, efficacy and metabolomic analysis.
    Katragadda U; Fan W; Wang Y; Teng Q; Tan C
    PLoS One; 2013; 8(3):e58619. PubMed ID: 23505544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect.
    Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J
    Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative evaluation of coenzyme Q10-loaded liposomes and solid lipid nanoparticles as dermal antioxidant carriers.
    Gokce EH; Korkmaz E; Tuncay-Tanrıverdi S; Dellera E; Sandri G; Bonferoni MC; Ozer O
    Int J Nanomedicine; 2012; 7():5109-17. PubMed ID: 23055723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E Succinate-Grafted-Chitosan Oligosaccharide/RGD-Conjugated TPGS Mixed Micelles Loaded with Paclitaxel for U87MG Tumor Therapy.
    Chen Y; Feng S; Liu W; Yuan Z; Yin P; Gao F
    Mol Pharm; 2017 Apr; 14(4):1190-1203. PubMed ID: 28212490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.
    Ren H; Gao C; Zhou L; Liu M; Xie C; Lu W
    Drug Deliv; 2015; 22(6):785-94. PubMed ID: 24670093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro- and nanoformulations of paclitaxel based on micelles, liposomes, cubosomes, and lipid nanoparticles: Recent advances and challenges.
    Alavi M; Nokhodchi A
    Drug Discov Today; 2022 Feb; 27(2):576-584. PubMed ID: 34688912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers.
    Haddadzadegan S; Dorkoosh F; Bernkop-Schnürch A
    Adv Drug Deliv Rev; 2022 Mar; 182():114097. PubMed ID: 34999121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles.
    Baek JS; Cho CW
    Int J Pharm; 2015 Jan; 478(2):617-24. PubMed ID: 25510604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major difference in particle size, minor difference in release profile: a case study of solid lipid nanoparticles.
    Huang Z; Wu L; Wang W; Wang W; Fu F; Zhang X; Huang Y; Pan X; Wu C
    Pharm Dev Technol; 2021 Dec; 26(10):1110-1119. PubMed ID: 34694203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.